Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Non-cash Items: 2012-2024

Historic Non-cash Items for Cytokinetics (CYTK) over the last 1 years, with Dec 2024 value amounting to $6.9 million.

  • Cytokinetics' Non-cash Items fell 5.50% to $6.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.9 million, marking a year-over-year decrease of 5.50%. This contributed to the annual value of $6.9 million for FY2024, which is 5.50% down from last year.
  • According to the latest figures from Q4 2024, Cytokinetics' Non-cash Items is $6.9 million, which was down 5.50% from $7.3 million recorded in Q4 2023.
  • Over the past 5 years, Cytokinetics' Non-cash Items peaked at $91.9 million during Q4 2020, and registered a low of $200,000 during Q3 2022.
  • Over the past 3 years, Cytokinetics' median Non-cash Items value was $3.3 million (recorded in 2022), while the average stood at $3.6 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first surged by 1,618.03% in 2020, then crashed by 93.66% in 2021.
  • Cytokinetics' Non-cash Items (Quarterly) stood at $91.9 million in 2020, then crashed by 93.66% to $5.8 million in 2021, then climbed by 5.57% to $6.2 million in 2022, then climbed by 18.29% to $7.3 million in 2023, then declined by 5.50% to $6.9 million in 2024.
  • Its Non-cash Items was $6.9 million in Q4 2024, compared to $7.3 million in Q4 2023 and $6.2 million in Q4 2022.